Kenvue (NYSE:KVUE) has announced a CEO transition and the launch of a strategic review process aimed at enhancing shareholder value and improving the long-term performance of the consumer health company. Kirk Perry, a Kenvue director with more than 30 years of experience in the consumer goods and technology sectors, has been appointed interim CEO, effective immediately.
Tylenol parent Kenvue Inc (NASDAQ:KVUE) is up 1.4% to trade at $21.64, after the company fired its CEO Thibaut Mongon amid efforts to revamp performance.
The company, formerly part of Johnson & Johnson, says it is taking steps ‘to accelerate profitable growth.'
![]() KVUE In 3 weeks Estimated | Quarterly | $0.2 Per Share |
![]() KVUE 2 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 5 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 8 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 11 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 7 May 2024 Paid | Quarterly | $0.2 Per Share |
7 Aug 2025 (In 2 weeks) Date | | 0.28 Cons. EPS | - EPS |
5 Aug 2025 (In 1 week) Date | | 0.28 Cons. EPS | - EPS |
5 May 2025 Date | | 0.23 Cons. EPS | 0.24 EPS |
6 Feb 2025 Date | | 0.31 Cons. EPS | 0.26 EPS |
7 Nov 2024 Date | | 0.27 Cons. EPS | 0.28 EPS |
![]() KVUE In 3 weeks Estimated | Quarterly | $0.2 Per Share |
![]() KVUE 2 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 5 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 8 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 11 months ago Paid | Quarterly | $0.2 Per Share |
![]() KVUE 7 May 2024 Paid | Quarterly | $0.2 Per Share |
7 Aug 2025 (In 2 weeks) Date | | 0.28 Cons. EPS | - EPS |
5 Aug 2025 (In 1 week) Date | | 0.28 Cons. EPS | - EPS |
5 May 2025 Date | | 0.23 Cons. EPS | 0.24 EPS |
6 Feb 2025 Date | | 0.31 Cons. EPS | 0.26 EPS |
7 Nov 2024 Date | | 0.27 Cons. EPS | 0.28 EPS |
Household & Personal Products Industry | Consumer Defensive Sector | Thibaut Mongon CEO | NYSE Exchange | 49177J102 Cusip |
US Country | 22,000 Employees | 14 May 2025 Last Dividend | - Last Split | 4 May 2023 IPO Date |
Kenvue Inc. is a global consumer health firm that offers a wide range of healthcare products through its diverse operational segments: Self Care, Skin Health and Beauty, and Essential Health. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue Inc. delivers a comprehensive portfolio of products designed to improve the wellness and health of consumers around the world. By leveraging well-known brands across its segments, Kenvue provides solutions for everyday health concerns, from pain relief and cold prevention to skincare and baby care.